EXONDYS 51 ETEPLIRSEN INJECTION

Serial Number 87656211
Registration 5490967
702

Registration Progress

Application Filed
Oct 23, 2017
Under Examination
Approved for Publication
Mar 27, 2018
Published for Opposition
Mar 27, 2018
Registered
Jun 12, 2018

Trademark Image

EXONDYS 51 ETEPLIRSEN INJECTION

Basic Information

Serial Number
87656211
Registration Number
5490967
Filing Date
October 23, 2017
Registration Date
June 12, 2018
Published for Opposition
March 27, 2018
Drawing Code
3

Status Summary

Current Status
Active
Status Code
702
Status Date
Nov 6, 2024
Registration
Registered
Classes
044

Rights Holder

Sarepta Therapeutics, Inc.

03
Address
215 First Street
Cambridge, MA 02142

Ownership History

Sarepta Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Sarepta Therapeutics, Inc.

Owner at Publication
03
Cambridge, MA

Sarepta Therapeutics, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Maury M. Tepper, III

USPTO Deadlines

Next Deadline
1046 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-06-12)
Due Date
June 12, 2028
Grace Period Ends
December 12, 2028

Application History

23 events
Date Code Type Description Documents
Nov 6, 2024 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Nov 6, 2024 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Nov 6, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
May 17, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jun 12, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jan 22, 2020 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 12, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 27, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 27, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 7, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 22, 2018 ALIE A ASSIGNED TO LIE Loading...
Feb 9, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 9, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 9, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 9, 2018 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 9, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 8, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 8, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 8, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 31, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 2, 2017 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 1, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 26, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Providing health information
First Use Anywhere: Dec 9, 2016
First Use in Commerce: Dec 9, 2016

Additional Information

Design Mark
The mark consists of a hexagon, bisected by a swoosh, followed by the text and numeral "EXONDYS 51" over the text (eteplirsen) Injection; the color gray is intended to show shading or contrast only.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
EXONDYS FIFTY ONE ETEPLIRSEN INJECTION

Classification

International Classes
044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"51 ETEPLIRSEN INJECTION"